نتایج جستجو برای: ssri selective serotonin re

تعداد نتایج: 400567  

Journal: :Sleep research online : SRO 1998
R Ursin B Bjorvatn

Adenosine is currently being investigated as a possible mediator of a homeostatic sleep need. Reports from different laboratories suggest that both adenosine A1 agonists and selective serotonin reuptake inhibitors (SSRI) increase deep slow wave sleep (SWS-2) after an interval. In this study, the sleep-wake effects of the adenosine A1 agonist N6-cyclopentyladenosine (CPA) and the SSRI zimeldine ...

2010
Jill Venton

The serotonin transporter (SERT) plays a key role in regulating serotonin signaling by clearing serotonin from the extracellular space and recycling it to the intracellular space where it can be repackaged into vesicles (Murphy et al. 2004). Polymorphisms conferring decreased SERT activity have been associated with anxiety and the development of depression under stressful conditions (Murphy et ...

2015
Yuan-Lung Cheng Hsiao-Yun Hu Xi-Hsuan Lin Jiing-Chyuan Luo Yen-Ling Peng Ming-Chih Hou Han-Chieh Lin Fa-Yauh Lee Mohammad Derakhshan.

Selective serotonin receptor inhibitor (SSRI) and serotonin-noradrenaline reuptake inhibitor (SNRI) users have been reported to have an increased risk of upper gastrointestinal bleeding (UGIB), but their association with lower gastrointestinal bleeding (LGIB) is less studied. This study aimed to analyze the incidence of UGIB and LGIB among SSRI users, SNRI users, and controls.Using the National...

Journal: :Psychotherapy and psychosomatics 2015
Giovanni A Fava Alessia Gatti Carlotta Belaise Jenny Guidi Emanuela Offidani

Background: Selective serotonin reuptake inhibitors (SSRI) are widely used in medical practice. They have been associated with a broad range of symptoms, whose clinical meaning has not been fully appreciated. Methods: The PRISMA guidelines were followed to conduct a systematic review of the literature. Titles, abstracts, and topics were searched using the following terms: 'withdrawal symptoms' ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
John R Cirrito Brianne M Disabato Jessica L Restivo Deborah K Verges Whitney D Goebel Anshul Sathyan Davinder Hayreh Gina D'Angelo Tammie Benzinger Hyejin Yoon Jungsu Kim John C Morris Mark A Mintun Yvette I Sheline

Aggregation of amyloid-β (Aβ) as toxic oligomers and amyloid plaques within the brain appears to be the pathogenic event that initiates Alzheimer's disease (AD) lesions. One therapeutic strategy has been to reduce Aβ levels to limit its accumulation. Activation of certain neurotransmitter receptors can regulate Aβ metabolism. We assessed the ability of serotonin signaling to alter brain Aβ leve...

Journal: :Neuro-Oncology Practice 2023

Abstract Background Depression and treatment with antidepressant medication is common in patients malignant glioma. However, the extent to which antidepressants may affect disease not fully understood. Therefore, purpose of present study was investigate possible associations between survival glioma patients. Methods We performed a registry-based cohort including 1231 (WHO grades 2, 3, 4) having...

2012
Gary J. Kummet Sarah E. Haskell Gregory M. Hermann Charles Ni Kenneth A. Volk Areej K. Younes Alise K. Miller Robert D. Roghair

Background. Selective serotonin reuptake inhibitor (SSRI) therapy complicates up to 10% of pregnancies. During therapy, SSRIs exert pleiotropic antidepressant, anorexigenic, and neurotrophic effects. Intrauterine SSRI exposure has been modeled by neonatal administration to developmentally immature rodents, and it has paradoxically elicited features of adult depression. We hypothesized neonatal ...

2010
Isabelle Malagié Denis J. David Pascale Jolliet René Hen Michel Bourin Alain M. Gardier

To test for the contribution of the 5-HT1B receptor subtype in mediating the effects of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), we used intracerebral in vivo microdialysis in awake, freely moving 5-HT1B receptor knock-out mice. We show that a single systemic administration of fluoxetine (1, 5 or 10 mg/kg, i.p.) increased extracellular serotonin levels [5-HT]ext in the ventr...

2009
Eli Lilly

Anecdotal reports have suggested that selective serotonin reuptake inhibitors (SSRIs) may cause suicidal or violent behavior in some patients. Because of the publicity surrounding certain events, and the numerous lawsuits that have been filed, a review of benefits and risks is needed. At most 30% of patients receive a benefit from SSRIs beyond the large placebo effect in certain mental conditio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید